Precise Local Injection of Anti-cancer Drugs Using Presage's CIVO Device in Soft Tissue Sarcoma
Status:
Completed
Trial end date:
2021-09-22
Target enrollment:
Participant gender:
Summary
This is a feasibility study in patients with localized or metastatic soft tissue sarcoma
undergoing surgery to determine how sarcoma in situ responds to injected microdoses of
anti-cancer therapeutics.
Phase:
Phase 1
Details
Lead Sponsor:
Presage Biosciences
Collaborators:
Fred Hutchinson Cancer Research Center Northwell Health Oregon Health and Science University University of Washington